Strategies to influence PVR development

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 242, Issue 8, 2004, Pages 699-703

  Kirchhof, Bernd ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; CYTOSTATIC AGENT; DAUNORUBICIN; DEXAMETHASONE; FLUOROACETIC ACID; FLUOROURACIL; HEPARIN; HYALURONIC ACID; LIPOSOME; MICROSPHERE; OXANE HD; PACLITAXEL; RETINOIC ACID; SILICONE OIL; TRANSFORMING GROWTH FACTOR BETA3;

ACCIDENT PREVENTION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; EYE INJURY; EYE TOXICITY; HUMAN; INTRAOCULAR FOREIGN BODY; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA SURGERY; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SUSTAINED DRUG RELEASE; VITRECTOMY; VITREORETINOPATHY;

CHEMOTHERAPY, ADJUVANT; EYE INJURIES, PENETRATING; FIBROBLASTS; HUMANS; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; WOUND HEALING;

EID: 4544361714     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0978-8     Document Type: Review

References (48)

1. Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B (2003) One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 87:615-621
2. Abrams GW, Azen SP, McCuen BW, Flynn HW Jr, Lai MY, Ryan SJ (1997) Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone study report 11. Arch Ophthalmol 115:335-344
3. Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R, Thumann G, Fricke J, Neugebauer A, Hilgers RD, Esser P, Walter P, Bartz-Schmidt KU (2002) Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 120:451-459
4. Allinson RW (2002) Adjuvant 5-FU and heparin prevent PVR. Ophthalmology 109:829-830
5. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreo-retinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 108:1179-1183
6. Bartz-Schmidt KU, Kirchhof B, Heimann K (1996) Primary vitrectomy for pseudophakic retinal detachment. Br J Ophthalmol 80:346-349,
7. Binder S, Bonnet M, Velikay M, Gerard JP, Stolba U, Wedrich A, Hohenberg H (1994) Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study. Graefes Arch Clin Exp Ophthalmol 232:211-214
8. van Bockxmeer FM, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140-1147
9. Brazitikos PD, D'Amico DJ, Tsinopoulos IT, Stangos NT (1999) Primary vitrectomy with perfluoro-n-octane use in the treatment of pseudophakic retinal detachment with undetected retinal breaks. Retina 19:103-109
10. Cardillo JA, Stout JT, LaBree L, Azen SP, Omphroy L, Cui JZ, Kimura H, Hinton DR, Ryan SJ (1997) Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104:1166-1173
11. Coleman DJ (1982) Early vitrectomy in the management of the severely traumatized eye. Am J Ophthalmol 93:543-551
12. Conway BP, Michels RG (1978) Vitrectomy techniques in the management of selected penetrating ocular injuries. Ophthalmology 85:560-583
13. Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M (1998) Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39:164-170
14. Faulborn J, Atkinson A, Olivier D (1977) Primary vitrectomy as a preventive surgical procedure in the treatment of severely injured eyes. Br J Ophthalmol 61:202-208
15. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Stalmans P (2002) Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch ophthamol 120:141-144
16. Fong LP, Taouk Y (1995) The role of eye protection in work-related eye injuries. Aust NZ J Ophthalmol 23:101-106
17. Gabbiani G, Badonnel MC (1976) Contractile events during inflammation. Agents Actions 6:277-280
18. Heimann H, Bornfeld N, Friedrichs W, Helbig H, Kellner U, Korra A, Foerster MH (1996) Primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 234:561-568
19. Heimann H, Hellmich M, Bornfeld N, Bartz-Schmidt KU, Hilgers RD, Foerster MH (2001) Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment (SPR Study): design issues and implications. SPR study report no. 1. Graefes Arch Clin Exp Ophthalmol 239:567-574
20. Herrero-Vanrell R, Refojo MF (2001) Biodegradable microspheres for vitreo-retinal drug delivery. Adv Drug Deliv Rev 52:5-16
21. Jolimaitre P, Malet-Martino M, Martino R (2003) Fluorouracil prodrugs for the treatment of proliferative vitreo-retinopathy: formulation in silicone oil and in vitro release of fluorouracil. Int J Pharm 259:181-192
22. Joussen AM, Walter P, Jonescu-Cuypers CP, Koizumi K, Poulaki V, Bartz-Schmidt KU, Krieglstein GK, Kirchhof B (2003) Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol 87:1094-1102
23. Karel I, Michalickova M, Kuthan P (1997) Long-term results of pars plana vitrectomy and silicone oil in large retinal tears in children. Cesk Slov Oftalmol 53:147-154
24. Koerner F, Merz E, Wagner A, Gloor B (1988) Proliferative vitreoretinopathy: relation to the extent of retinal detachment, size of retinal tears and coagulation surface. Klin Monatsbl Augenheilkd 192:465-467
25. Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW (2000) Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 84:506-511
26. Lemmen KD, Heimann K (1988) Early vitrectomy with primary silicone oil injection in very severely injured eyes. Klin Monatsbl Augenheilkd 193:594-601
27. Lemor M, Yeo JH, Glaser BM (1986) Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol 104:1226-1229
28. Longaker MT, Chiu ES, Harrison MR, Crombleholme TM, Langer JC, Duncan BW, Adzick NS, Verrier ED, Stern R (1989) Studies in fetal wound healing. IV. Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid. Ann Surg 210:667-672
29. Lund OE (1986) Incidence of injuries caused by windshields following implementation of the 1984 seat belt law. Fortschr Ophthalmol 83:420-421
30. Machemer R (1968) Experimental retinal detachment in the owl monkey. II. Histology of retina and pigment epithelium. Am J Ophthalmol 66:396-410
31. Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77:171-180
32. Meredith JE Jr, Fazeli B, Schwartz MA (1993) The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953-961
33. Rowlatt U (1979) Intrauterine wound healing in a 20 week human fetus. Virchows Arch A Pathol Anat Histol 381:353-361
34. Ryan SJ, Allen AW (1979) Pars plana vitrectomy in ocular trauma. Am J Ophthalmol 88:483-491
35. Scott IU, Flynn HW Jr, Azen SP, Lai MY, Schwartz S, Trese MT (1999) Silicone oil in the repair of pediatric complex retinal detachments: a prospective, observational, multicenter study. Ophthalmology 106:1399-1407
36. Shah M, Foreman DM, Ferguson MW (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339:213-214
37. Shinohara K, Tanaka M, Sakuma T, Kobayashi Y (2003) Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 34:299-305
38. Stelnicki EJ, Arbeit J, Cass DL, Saner C, Harrison M, Largman C (1998) Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless fetal wounds. J Invest Dermatol 111:57-63
39. Weller M, Wiedemann P, Heimann K (1990) Proliferative vitreoretinopathy - is it anything more than wound healing at the wrong place? Int Ophthalmol 14:105-117
40. Wetterqvist C, Wong D, Williams R, Stappler T, Herbert E, Freeburn S (2004) Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol 88:692-696
41. Wiedemann P, Heimann K (1986) Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs. Klin Monatsbl Augenheilkd 188:559-564
42. Williams RG, Chang S, Comaratta MR, Simoni G (1996) Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234:496-503
43. Wolf S, Lappas A, Weinberger AW, Kirchhof B (1999) Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: first results. Graefes Arch Clin Exp Ophthalmol 237:51-57
44. Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture ("heavy silicone oil") as internal tamponade for complicated retinal detachment. Retina 23:335-342
45. Wong D, Stanga P, Briggs M, Lenfestey P, Lancaster E, Li KK, Lim KS, Groenewald C (2004) Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol 88:186-190
46. Wu WC, Kao YH, Hu DN (2002) A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro. J Ocul Pharmacol Ther 18:251-264
47. Yasukawa T, Kimura H, Tabata Y, Ogura Y (2001) Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 52:25-36
48. Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17-24